Nevertheless, a tumor suppressor role of FTO has been described in intrahepatic cholangiocarcinoma (ICC) by controlling different pathways, including EGFR, and by decreasing the stability of the oncogene TEAD2 [271]. The gene discussed is FTO; the disease is intrahepatic cholangiocarcinoma.